NOTCH1 and adrenal cortex carcinoma: [7] found that NOTCH1 mutations define an aggressive ACC subgroup with poor outcomes, proposing nuclear expression of the NOTCH1 intracellular domain (NICD1) as a potential prognostic biomarker.